{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:59:11Z","timestamp":1794693551384,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Salmonella typhimurium<\/jats:italic> VNP-20009 (VNP) is a non-pathogenic attenuated strain, which, as a facultative anaerobe, preferentially accumulates in hypoxic regions of solid tumors. Here, VNP was utilized as a delivery vehicle of the anti-tumor protein Lipidated azurin, Laz, which is produced by the meningitis-causing bacterium <jats:italic>Neisseria meningitides<\/jats:italic>. In brain cancer cells, Laz has been demonstrated to induce apoptosis through an interaction with the tumor suppressor protein p53. In this study, the <jats:italic>laz<\/jats:italic> gene, including its signal sequence, was cloned downstream of a hypoxia inducible promoter (HIP-1), before being electroporated into VNP. Successful ectopic expression and export of the Laz protein by VNP under hypoxic conditions were confirmed by Western blot analysis of the cell-free culture medium. Effective expression of Laz by VNP was investigated in two glioblastoma cell lines: LN-229 and U-373, with the latter line carrying a mutated version of p53; as well as in the breast cancer line MCF-7. Cytotoxicity of the VNP-Laz was assessed by determining the fluorescence of the apoptotic marker caspases 3\/7. Compared to the purified Laz, VNP-Laz, significantly induced apoptosis in MCF-7, LN-229 and, to a much lower extent in U-373 cells, suggesting a p53-linked mechanism. Our results might represent a new approach of targeted gene delivery and suggest a potential application in brain tumor therapy.<\/jats:p>","DOI":"10.1186\/s13568-020-00995-8","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T08:03:01Z","timestamp":1585296181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Bacterial delivery of the anti-tumor azurin-like protein Laz to glioblastoma cells"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-4087","authenticated-orcid":false,"given":"Manar","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehab","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Abou-Aisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"issue":"1","key":"995_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/dmd.112.048322","volume":"41","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Manchanda P, Vogelbaum MA, Ohlfest JR, Elmquist WF (2013) Function of the blood\u2013brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma. Drug Metab Dispos 41(1):33\u201339","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"995_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.bbrc.2005.05.038","volume":"332","author":"D Apiyo","year":"2005","unstructured":"Apiyo D, Wittung-Stafshede P (2005) Unique complex between bacterial azurin and tumor-suppressor protein P53. Biochem Biophys Res Commun 332(4):965\u2013968","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"995_CR3","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-08-0552","volume":"68","author":"Nabil Arrach","year":"2008","unstructured":"Arrach Nabil, Zhao Ming, Porwollik Steffen, Hoffman Robert M, McClelland Michael (2008) Salmonella promoters preferentially activated inside tumors. Cancer Res 68(12):4827\u20134832","journal-title":"Cancer Res"},{"issue":"6","key":"995_CR4","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1158\/0008-5472.CAN-09-4005","volume":"70","author":"N Arrach","year":"2010","unstructured":"Arrach N, Cheng P, Zhao M, Santiviago CA, Hoffman RM, Mcclelland M (2010) Retain targeting of solid tumors. Cancer Res 70(6):2165\u20132170","journal-title":"Cancer Res"},{"key":"995_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.00001","volume":"9","author":"BI Baarda","year":"2018","unstructured":"Baarda BI, Zielke RA, Jerse AE, Sikora AE (2018) Lipid-modified azurin of Neisseria gonorrhoeae is not surface exposed and does not interact with the nitrite reductase AniA. Front Microbiol 9:1\u201315","journal-title":"Front Microbiol"},{"issue":"6","key":"995_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4161\/bbug.1.6.13146","volume":"1","author":"CK Baban","year":"2010","unstructured":"Baban CK, Cronin M, O\u2019Hanlon D, O\u2019Sullivan GC, Tangney M (2010) Bacteria as vectors for gene therapy of cancer. Bioeng Bugs 1(6):385\u2013394","journal-title":"Bioeng Bugs"},{"issue":"Part A","key":"995_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jbiotec.2014.07.006","volume":"192","author":"KM Broadway","year":"2014","unstructured":"Broadway KM, Modise T, Jensen RV, Scharf BE (2014) Complete genome sequence of Salmonella enterica serovar Typhimurium VNP20009, a strain engineered for tumor targeting. J Biotechnol 192(Part A):177\u2013178","journal-title":"J Biotechnol"},{"issue":"8","key":"995_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.bbagen.2007.05.004","volume":"1770","author":"A Buffon","year":"2007","unstructured":"Buffon A, Wink MR, Ribeiro BV, Casali EA, Libermann TA, Zerbini LF, Robson SC, Sarkis JJF (2007) NTPDase and 5\u2032 ecto-nucleotidase expression profiles and the pattern of extracellular ATP metabolism in the walker 256 tumor. Biochim Biophys Acta Gen Subj 1770(8):1259\u20131265","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"7","key":"995_CR9","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1021\/bi061661x","volume":"46","author":"A Chaudhari","year":"2007","unstructured":"Chaudhari A, Mahfouz M, Fialho AM, Yamada T, Granja AT, Zhu Y, Hashimoto W, Schlarb-Ridley B, Cho W, Das Gupta TK, Chakrabarty AM (2007) Cupredoxin-cancer interrelationship: azurin binding with Eph B2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth. Biochemistry 46(7):1799\u20131810","journal-title":"Biochemistry"},{"issue":"20","key":"995_CR10","doi-asserted-by":"publisher","first-page":"33601","DOI":"10.18632\/oncotarget.16830","volume":"8","author":"SL Coutermarsh-ott","year":"2017","unstructured":"Coutermarsh-ott SL, Broadway KM, Scharf BE, Allen C (2017) Effect of Salmonella enterica serovar Typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression. Oncotarget 8(20):33601\u201333613","journal-title":"Oncotarget"},{"issue":"5","key":"995_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0155338","volume":"11","author":"IV Deyneko","year":"2016","unstructured":"Deyneko IV, Kasnitz N, Leschner S, Weiss S (2016) Composing a tumor specific bacterial promoter. PLoS ONE 11(5):1\u201317","journal-title":"PLoS ONE"},{"issue":"21","key":"995_CR12","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1158\/0008-5472.CAN-12-1600","volume":"72","author":"V Di Francesco","year":"2012","unstructured":"Di Francesco V (2012) Purines, purinergic receptors, and cancer. Cancer Res 72(21):5441\u20135447","journal-title":"Cancer Res"},{"key":"995_CR13","doi-asserted-by":"publisher","DOI":"10.5171\/2012.125978","author":"A El-Bahy","year":"2012","unstructured":"El-Bahy A, Abou-Aisha K, Noaman E, Mahran L (2012) Regression of murine ehrlich ascites carcinoma using tumor-targeting Salmonella VNP20009\u2014comparison with the effect of the anticancer drug doxorubicin. Adv Cancer Res Treat. https:\/\/doi.org\/10.5171\/2012.125978","journal-title":"Adv Cancer Res Treat"},{"issue":"11","key":"995_CR14","first-page":"785","volume":"10","author":"NS Forbes","year":"2013","unstructured":"Forbes NS (2013) NIH public access. Eng Perfect 10(11):785\u2013794","journal-title":"Eng Perfect"},{"issue":"6","key":"995_CR15","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1349-7006.2008.00808.x","volume":"99","author":"W Fu","year":"2008","unstructured":"Fu W, Lan H, Liang S, Gao T, Ren D (2008) Suicide gene\/prodrug therapy using salmonella-mediated delivery of Escherichia coli purine nucleoside phosphorylase gene and 6-Methlpurine 2\u2032-Deoxyriboside in murine mammary carcinoma 4T1 model. Cancer Sci 99(6):1172\u20131179","journal-title":"Cancer Sci"},{"issue":"9","key":"995_CR16","first-page":"1120","volume":"5","author":"AM Gene","year":"2006","unstructured":"Gene AM, Dubois L, Lambin P, Landuyt W, Chiu RK, Wouters BG, Theys J (2006) Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated salmonella. Therapy 5(9):1120\u20131128","journal-title":"Therapy"},{"issue":"3","key":"995_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1042\/bj3160887","volume":"316","author":"J Green","year":"1996","unstructured":"Green J, Bennett B, Jordan P, Ralph ET, Thomson AJ, Guest JR (1996) Reconstitution of the [4Fe-4S] cluster in FNR and demonstration of the aerobic-anaerobic transcription switch in vitro. Biochem J 316(3):887\u2013892","journal-title":"Biochem J"},{"issue":"3","key":"995_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/21655979.2015.1022303","volume":"6","author":"W Hashimoto","year":"2015","unstructured":"Hashimoto W, Ochiai A, Hong CS, Murata K, Chakrabarty AM (2015) Structural studies on Laz, a promiscuous anticancer Neisserial protein. Bioengineered 6(3):141\u2013148","journal-title":"Bioengineered"},{"issue":"3","key":"995_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/BF00763177","volume":"22","author":"S Hayashi","year":"1990","unstructured":"Hayashi S, Wu C (1990) MINI-REVIEW Lipoproteins in Bacteria. J Bioenerg Biomembr 22(3):451\u2013471","journal-title":"J Bioenerg Biomembr"},{"issue":"15","key":"995_CR20","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.4161\/cc.5.15.2991","volume":"5","author":"CS Hong","year":"2006","unstructured":"Hong CS, Yamada T, Hashimoto Wa, Fialho AM, Das Gupta TK, Chakrabarty AM (2006) Disrupting the entry barrier and attacking brain tumors: the role of the Neisseria H.8 epitope and the Laz protein. Cell Cycle 5(15):1633\u20131641","journal-title":"Cell Cycle"},{"issue":"29","key":"995_CR21","first-page":"2649","volume":"56","author":"PM Howley","year":"1996","unstructured":"Howley PM, Maki CG, Huibregtse JM (1996) In vivo ubiquitination and proteasome-mediated degradation of P531. Cancer Res 56(29):2649\u20132654","journal-title":"Cancer Res"},{"issue":"7","key":"995_CR22","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1128\/JCM.34.7.1646-1648.1996","volume":"34","author":"A Imhof","year":"1996","unstructured":"Imhof A, Heinzer I (1996) Continuous monitoring of oxygen concentrations in several systems for cultivation of anaerobic bacteria. J Clin Microbiol 34(7):1646\u20131648","journal-title":"J Clin Microbiol"},{"issue":"3","key":"995_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0014-5793(97)01219-2","volume":"416","author":"PA Jordan","year":"1997","unstructured":"Jordan PA, Thomson AJ, Ralph ET, Guest JR, Green J (1997) FNR Is a direct oxygen sensor having a biphasic response curve. FEBS Lett 416(3):349\u2013352","journal-title":"FEBS Lett"},{"issue":"4","key":"995_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/bit.20883","volume":"94","author":"RW Kasinskas","year":"2006","unstructured":"Kasinskas RW, Forbes NS (2006) Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol Bioeng 94(4):710\u2013721","journal-title":"Biotechnol Bioeng"},{"issue":"7","key":"995_CR25","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1073\/pnas.92.7.2499","volume":"92","author":"N Khoroshilova","year":"2006","unstructured":"Khoroshilova N, Beinert H, Kiley PJ (2006) Association of a polynuclear iron-sulfur center with a mutant FNR protein enhances DNA binding. Proc Natl Acad Sci 92(7):2499\u20132503","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"995_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1369-5274(03)00039-0","volume":"6","author":"PJ Kiley","year":"2003","unstructured":"Kiley PJ, Beinert H (2003) The role of Fe-S proteins in sensing and regulation in bacteria. Curr Opin Microbiol 6(2):181\u2013185","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"995_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/156652409788167113","volume":"9","author":"Y Kim","year":"2009","unstructured":"Kim Y, Lin Q, Glazer PM, Yun Z (2009) Hypoxic tumor microenvironment and cancer cell differentiation. Curr Mol Med 9(4):425\u2013434","journal-title":"Curr Mol Med"},{"issue":"8","key":"995_CR28","doi-asserted-by":"publisher","first-page":"e6692","DOI":"10.1371\/journal.pone.0006692","volume":"4","author":"S Leschner","year":"2009","unstructured":"Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H, Weiss S (2009) Tumor invasion of Salmonella enterica serovar typhimurium is accompanied by strong hemorrhage promoted by TNF-\u03b1. PLoS One 4(8):e6692. https:\/\/doi.org\/10.1371\/journal.pone.0006692","journal-title":"PLoS One"},{"issue":"7","key":"995_CR29","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1093\/nar\/gkr1041","volume":"40","author":"S Leschner","year":"2012","unstructured":"Leschner S, Deyneko IV, Lienenklaus S, Wolf K, Bloecker H, Bumann D, Loessner H, Weiss S (2012) Identification of tumor-specific Salmonella typhimurium promoters and their regulatory logic. Nucleic Acids Res 40(7):2984\u20132994","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"995_CR30","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3892\/ol.2014.2525","volume":"8","author":"S Liu","year":"2014","unstructured":"Liu S, Xiaoping X, Zeng X, Li L, Chen Q, Li J (2014) Tumor-targeting bacterial therapy: a potential treatment for oral cancer. Oncol Lett 8(6):2359\u20132366","journal-title":"Oncol Lett"},{"issue":"1","key":"995_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/5205","volume":"17","author":"KB Low","year":"1999","unstructured":"Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J, Lin SL, Luo X, Miller SI, Zheng L, King I, Pawelek JM, Bermudes D (1999) Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol 17(1):37\u201341","journal-title":"Nat Biotechnol"},{"issue":"1","key":"995_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.plasmid.2006.11.001","volume":"57","author":"M Mahfouz","year":"2007","unstructured":"Mahfouz M, Hashimoto W, Das Gupta TK, Chakrabarty AM (2007) Bacterial proteins and CpG-rich extrachromosomal DNA in potential cancer therapy. Plasmid 57(1):4\u201317","journal-title":"Plasmid"},{"issue":"20","key":"995_CR33","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.7150\/jca.32650","volume":"10","author":"Z Mi","year":"2019","unstructured":"Mi Z, Feng ZC, Li C, Yang X, Ma MT, Rong PF (2019) Salmonella-mediated cancer therapy: an innovative therapeutic strategy. J Cancer 10(20):4765\u20134776","journal-title":"J Cancer"},{"issue":"4","key":"995_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00330-006-0431-y","volume":"17","author":"AR Padhani","year":"2007","unstructured":"Padhani AR, Krohn KA, Lewis JS, Alber M (2007) Imaging oxygenation of human tumours. Eur Radiol 17(4):861\u2013872","journal-title":"Eur Radiol"},{"key":"995_CR35","first-page":"4537","volume":"57","author":"JM Pawelek","year":"1997","unstructured":"Pawelek JM, Brooks Low K, Bermudes D (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57:4537\u20134544","journal-title":"Cancer Res"},{"issue":"7","key":"995_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0002599","volume":"3","author":"P Pellegatti","year":"2008","unstructured":"Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F (2008) Increased level of extracellular ATP at tumor sites. In vivo imaging with plasma membrane luciferase. PLoS ONE 3(7):1\u20139","journal-title":"PLoS ONE"},{"issue":"13","key":"995_CR37","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/sj.onc.1207376","volume":"23","author":"V Punj","year":"2004","unstructured":"Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, Graves J, Yamada T, Constantinou AI, Christov K, White B, Li G, Majumdar D, Chakrabarty AM, Das Gupta TK (2004) Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 23(13):2367\u20132378","journal-title":"Oncogene"},{"issue":"1","key":"995_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/bies.20336","volume":"28","author":"RM Ryan","year":"2006","unstructured":"Ryan RM, Green J, Lewis CE (2006) Use of bacteria in anti-cancer therapies. BioEssays 28(1):84\u201394","journal-title":"BioEssays"},{"issue":"3","key":"995_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/gt.2008.188","volume":"16","author":"RM Ryan","year":"2009","unstructured":"Ryan RM, Green J, Williams PJ, Tazzyman S, Hunt S, Harmey JH, Kehoe SC, Lewis CE (2009) Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene Ther 16(3):329\u2013339","journal-title":"Gene Ther"},{"key":"995_CR40","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.2174\/092986708785132997","volume":"15","author":"Y Singh","year":"2008","unstructured":"Singh Y, Palombo M, Sinko P (2008) Recent trends in targeted anticancer prodrug and conjugate design. Curr Med Chem 15:1802\u20131826","journal-title":"Curr Med Chem"},{"issue":"2","key":"995_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/0008-5472.CAN-08-2932","volume":"69","author":"BN Taylor","year":"2009","unstructured":"Taylor BN, Mehta RR, Yamada T, Lekmine F, Christov K, Chakrabarty AM, Green A, Bratescu L, Shilkaitis A, Beattie CW, Das Gupta TK (2009) Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Res 69(2):537\u2013546","journal-title":"Cancer Res"},{"issue":"8","key":"995_CR42","first-page":"1","volume":"3","author":"J Theys","year":"2015","unstructured":"Theys J, Lambin P (2015) Clostridium to Treat cancer: dream or reality? Ann Transl Med 3(8):1\u20134","journal-title":"Ann Transl Med"},{"issue":"1","key":"995_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso JF et al (2002) Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20(1):142\u2013152","journal-title":"J Clin Oncol"},{"issue":"2","key":"995_CR44","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/infdis\/161.2.336","volume":"161","author":"DL Trees","year":"2019","unstructured":"Trees DL, Spinola SM (2019) Localization of and immune response to the lipid-modified azurin of the pathogenic Neisseria. J Infect Dis 161(2):336\u2013339","journal-title":"J Infect Dis"},{"issue":"1","key":"995_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2007.10.034","volume":"259","author":"MQ Wei","year":"2008","unstructured":"Wei MQ, Mengesha A, Good D, Ann\u00e9 J (2008) Bacterial targeted tumour therapy-dawn of a new era. Cancer Lett 259(1):16\u201327","journal-title":"Cancer Lett"},{"issue":"5","key":"995_CR46","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1152\/ajpgi.00526.2009","volume":"298","author":"S Wu","year":"2010","unstructured":"Wu S, Ye Z, Liu X, Zhao Y, Xia Y, Steiner A, Petrof EO, Claud EC, Sun J (2010) Salmonella typhimurium infection increases p53 acetylation in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 298(5):784\u2013794","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"22","key":"995_CR47","doi-asserted-by":"publisher","first-page":"14098","DOI":"10.1073\/pnas.222539699","volume":"99","author":"T Yamada","year":"2002","unstructured":"Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, Majumdar D, Cunningham E, Das Gupta TK, Chakrabarty AM (2002a) Bacterial redox protein azurin, tumor suppressor protein P53, and regression of cancer. Proc Natl Acad Sci USA 99(22):14098\u201314103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"995_CR48","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.1128\/IAI.70.12.7054-7062.2002","volume":"70","author":"T Yamada","year":"2002","unstructured":"Yamada T, Goto M, Punj V, Zaborina O, Kimbara K, Das Gupta TK, Chakrabarty AM (2002b) The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein P53. Infect Immun 70(12):7054\u20137062","journal-title":"Infect Immun"},{"issue":"10","key":"995_CR49","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/j.1462-5822.2005.00567.x","volume":"7","author":"T Yamada","year":"2005","unstructured":"Yamada T, Fialho AM, Punj V, Bratescu L, Das Gupta TK, Chakrabarty AM (2005) Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. Cell Microbiol 7(10):1418\u20131431","journal-title":"Cell Microbiol"},{"key":"995_CR50","first-page":"1","volume":"2","author":"B Yu","year":"2012","unstructured":"Yu B, Yang M, Shi L, Yao Y, Jiang Q, Li X, Tang LH, Zheng BJ, Yuen KY, Smith DK, Song E, Huang JD (2012) Explicit hypoxia targeting with tumor suppression by creating an \u2018Obligate\u2019 Anaerobic Salmonella Typhimurium strain. Sci Rep 2:1\u201310","journal-title":"Sci Rep"},{"issue":"5","key":"995_CR51","first-page":"380","volume":"23","author":"M Zhao","year":"2005","unstructured":"Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM, Trump Donald L (2005) Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Urol Oncol Semin Orig Investig 23(5):380","journal-title":"Urol Oncol Semin Orig Investig"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-020-00995-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13568-020-00995-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-020-00995-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:16:14Z","timestamp":1616804174000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-020-00995-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1186\/s13568-020-00995-8","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"12 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}